Article Information
History
- July 13, 2023.
Article Versions
- Version 1 (March 31, 2023 - 14:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Catherine Hyams1,2,*,†,
- Robert Challen3,*,
- David Hettle4,
- Zahin Amin-Chowdhury5,
- Charli Grimes1,
- Gabriella Ruffino1,
- Rauri Conway1,
- Robyn Heath2,
- Paul North4,
- Adam Malin6,
- Nick A Maskell1,
- Philip Williams4,
- O. Martin Williams4,
- Shamez N Ladhani5,
- Leon Danon2,3 and
- Adam Finn1,2
- 1Academic Respiratory Unit, Learning and Research Building, Southmead Hospital, Bristol, UK
- 2Bristol Vaccine Centre, University of Bristol, Bristol, UK
- 3Engineering Mathematics, University of Bristol, Bristol, UK
- 4Department of Microbiology, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, UK
- 5Immunisation Department, UK Health Security Agency (UKHSA), London, UK
- 6Department of Respiratory Medicine, The Royal United Hospital, Bath, UK
- ↵†Corresponding author:
Dr Catherine Hyams, Bristol Vaccine Centre, 39-41 St Michael’s Hill University of Bristol, Bristol, UK catherine.hyams{at}bristol.ac.uk
↵* These authors contributed equally to the manuscript and should be considered co-first authors
Posted July 13, 2023.
Trends in serotype distribution and disease severity in adults hospitalised with Streptococcus pneumoniae infection in Bristol and Bath: a retrospective cohort study, 2006-2022
